(Q34880877)

5 August 2017

1 reference

title

The clinical value of erythropoietin in patients with cancer (English)

1 reference

5 August 2017

1 reference

Ulrich Dührsen

1

1 reference

5 August 2017

publication date

1 January 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

62

1 reference

5 August 2017

issue

14

1 reference

5 August 2017

page(s)

2013-2023

1 reference

Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice

5 August 2017

cites work

1 reference

12 December 2020

Efficacy of erythropoietin in the myelodysplastic syndromes: a meta-analysis of 205 patients from 17 studies

1 reference

12 December 2020

A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes

1 reference

12 December 2020

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group

1 reference

12 December 2020

What are cancer patients willing to pay for prophylactic epoetin alfa? A cost-benefit analysis

1 reference

12 December 2020

Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia

1 reference

12 December 2020

Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.

1 reference

12 December 2020

Economic analysis of expensive technologies: the case of erythropoietin

1 reference

12 December 2020

Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial.

1 reference

12 December 2020

Erythropoietin increases hemoglobin in cancer patients during radiation therapy

1 reference

12 December 2020

Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer

1 reference

12 December 2020

Beyond erythropoiesis: novel applications for recombinant human erythropoietin

1 reference

12 December 2020

Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial

1 reference

12 December 2020

Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx

1 reference

12 December 2020

Quality of life in clinical trials: assessment and utility with special reference to rHuEPO.

1 reference

12 December 2020

Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia

1 reference

12 December 2020

Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancy

1 reference

12 December 2020

Treatment of myelodysplastic syndromes with recombinant human erythropoietin.

1 reference

12 December 2020

Recombinant human erythropoietin in the treatment of the anaemia of cancer

1 reference

12 December 2020

Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo

1 reference

12 December 2020

Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin

1 reference

12 December 2020

Cost effectiveness, quality-adjusted life-years and supportive care. Recombinant human erythropoietin as a treatment of cancer-associated anaemia

1 reference

12 December 2020

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx

1 reference

12 December 2020

Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response

1 reference

12 December 2020

Biologic effects of leukocytes present in transfused cellular blood products.

1 reference

12 December 2020

Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients

1 reference

12 December 2020

Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study.

1 reference

12 December 2020

Erythropoietin and anemia of cancer

1 reference

12 December 2020

Cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemia

1 reference

12 December 2020

Radiotherapy and anaemia--the clinical experience

1 reference

12 December 2020

Erythropoietin restores the anemia-induced reduction in cyclophosphamide cytotoxicity in rat tumors

1 reference

12 December 2020

Anemia, hypoxia and transfusion in patients with cervix cancer: a review.

1 reference

12 December 2020

The frequency of red cell transfusion for anemia in patients receiving chemotherapy. A retrospective cohort study

1 reference

12 December 2020

Erythropoietin for patients undergoing radiotherapy: a pilot study

1 reference

12 December 2020

The significance of anemia in clinical radiation therapy

1 reference

12 December 2020

Blood transfusions and prognosis in colorectal cancer

1 reference

12 December 2020

Decreased erythropoietin response in patients with the anemia of cancer

1 reference

12 December 2020

A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy

1 reference

12 December 2020

Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials

1 reference

12 December 2020

Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma

1 reference

12 December 2020

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

1 reference

12 December 2020

The negative impact of anemia on radiotherapy and chemoradiation outcomes

1 reference

12 December 2020

Prognostic significance of anemia and role of erythropoietin in radiation therapy.

1 reference

12 December 2020

Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia

1 reference

12 December 2020

Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin

1 reference

12 December 2020

Tumor oxygenation in anemic rats: effects of erythropoietin treatment versus red blood cell transfusion

1 reference

12 December 2020

Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models

1 reference

12 December 2020

Prediction of response to erythropoietin treatment in chronic anemia of cancer.

1 reference

12 December 2020

Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group

1 reference

12 December 2020

Transfusion medicine. First of two parts--blood transfusion

1 reference

12 December 2020

Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27.

1 reference

12 December 2020

Blood flow, oxygenation, and bioenergetic status of tumors after erythropoietin treatment in normal and anemic rats

1 reference

12 December 2020

Phase I-II Trial of Erythropoietin in the Treatment of Cisplatin-Associated Anemia

1 reference

12 December 2020

Prediction of response to recombinant human erythropoietin (r-HuEPO/epoetin-alpha) therapy in cancer patients

1 reference

12 December 2020

Hematopoietic growth factors and the treatment of tumor-associated anemias

1 reference

12 December 2020

Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients

1 reference

12 December 2020

Chemotherapy-induced anemia in adults: incidence and treatment

1 reference

12 December 2020

Cost analysis of erythropoietin versus blood transfusions for cervical cancer patients receiving chemoradiotherapy

1 reference

12 December 2020

Cost of managing anemia with and without prophylactic epoetin alfa therapy in breast cancer patients receiving combination chemotherapy

1 reference

12 December 2020

1 reference

12 December 2020

Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy.

1 reference

12 December 2020

Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours

1 reference

12 December 2020

Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and N

1 reference

12 December 2020

Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.

1 reference

12 December 2020

Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model

1 reference

12 December 2020

10.2165/00003495-200262140-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

1037133553

0 references

1 reference